Exc tr-ext b9+marg 0.6-1 cm
CPT 11401 covers the removal of a benign (non-cancerous) skin growth from the face, neck, hands, feet, or genitals when the growth measures between 0.6 and 1.0 centimeters (about 1/4 to 1/2 inch) including the margin removed around it.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure the excised diameter (lesion plus margins) not the lesion alone. Document both pre-excision lesion size and post-excision specimen size in the operative note.
Impact: Prevents $40-60 downcoding from 11401 to 11400; incorrect measurement is the #1 reason for code-level denials
Bill in non-facility settings when possible. The practice receives the facility fee component of the RVU.
Impact: Increases reimbursement by $47.23 per procedure (difference between $151.06 non-facility and $103.83 facility rate)
When performing multiple excisions, list them in descending RVU order with modifier 51 on secondary procedures to maximize reimbursement.
Impact: Ensures highest-paying procedure receives 100% payment; can affect total reimbursement by 10-15% when billing 3+ excisions
Ensure pathology reports confirm benign diagnosis. If pathology reveals malignancy, submit corrected claim with appropriate malignant excision code (11600 series).
Impact: Malignant excision codes reimburse 15-30% higher; timely correction within filing limits prevents revenue loss of $30-80 per case
Verify anatomic site carefully. Lesions on face, ears, eyelids, nose, lips, or mucous membranes use 11440 series codes with higher reimbursement.
Impact: Face/special site codes reimburse approximately $175-225 vs $151 for 11401; misclassification costs $24-74 per procedure
Document medical necessity clearly, especially for cosmetic-appearing lesions. Include symptoms (bleeding, irritation, catching on clothing) or clinical concern for transformation.
Reduces denial rate by 25-40%; cosmetic denials result in 100% revenue loss ($151.06) and patient satisfaction issues
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.